52057EGP
- Active ingredient
- pralatrexate
- Strength
- 20mg/ml
- Form
- vial
- Manufacturer
- mundipharma > multipharma
- Route
- injection
Uses
Antineoplastic agent indicated for relapsed or refractory peripheral T-cell lymphoma.
Do not use if
No absolute contraindications listed; avoid use in patients with known hypersensitivity.
Side effects
Myelosuppression, mucositis, skin reactions, hepatic toxicity, and tumor lysis syndrome may occur.
Warnings
Monitor blood counts, mucositis, liver function, and serious skin reactions.
How it works
Folate analog metabolic inhibitor that interferes with DNA synthesis in malignant cells.
Storage
Store according to labeled conditions and protect vial integrity.